C

Centricity Research | Centricity Research Halifax

Research site
(Unclaimed)
Location
36 solutions drive suite 420, Halifax, Nova Scotia, Canada
Site insights

Top conditions

Alzheimer Disease (5 trials)

Tremor (1 trial)

Migraine Disorders (1 trial)

Alcoholism (1 trial)

Huntington Disease (1 trial)

Top treatments

ALZ-801
Gantenerumab
BOTOX
Aducanumab
Psilocybin
ABBV-916
ALZ- 801

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

8 of 9
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elderly population. Cli...

Enrolling
Alzheimer's Disease (AD)
Drug: Placebo
Drug: ABBV-916

The primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment a...

Active, not recruiting
Alzheimer's Disease
Drug: Aducanumab
Drug: Placebo

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. Th...

Active, not recruiting
Early Alzheimer's Disease
Drug: Experimental: ALZ-801
Drug: Placebo Comparator: Placebo

The purpose of this study is to compare the efficacy and safety of daily and every other day dosing of rimegepant to placebo as a preventive treatmen...

Active, not recruiting
Migraine
Drug: Rimegepant 75mg daily dosing
Drug: Placebo comparator dosing

This study will evaluate the safety, biomarkers, and efficacy of tominersen compared with placebo in participants with prodromal and early manifest H...

Enrolling
Huntington Disease
Drug: Tominersen 100 mg
Drug: Tominersen 60 mg

This study is being conducted to evaluate the long-term safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 ge...

Not yet enrolling
Early Alzheimer's Disease
Drug: Experimental: ALZ-801

The goal of this clinical trial is to investigate treatment with psilocybin and psychotherapy for the treatment of people with Alcohol Use Disorder (...

Enrolling
Alcohol Use Disorder
Drug: Psilocybin
Drug: Placebo

Upper limb essential tremor (UL ET) is a movement disorder characterized by postural and/or kinetic tremor. It can cause difficulty with everyday tas...

Enrolling
Upper Limb Essential Tremor (UL ET)
Biological: BOTOX
Drug: Placebo for BOTOX

Trial sponsors

AbbVie logo

AbbVie (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems